Page 22 - Sun Pharma
Sun Pharma buys skin cancer drug Odomzo for $175 mn from Novartis
Sun Pharmaceutical was approved by the US drug regulator in July 2015
 "Sun Pharma buys skin cancer drug Odomzo for $175 mn from Novartis")
Sun Pharma steps up specialty biz, acquires cancer drug in $175 mn deal
The transaction gives Sun Pharma its first branded oncology product
 "Sun Pharma steps up specialty biz, acquires cancer drug in $175 mn deal")
Sun Pharma Advanced Research, Sun Pharma gain in weak market
SPARC was up 4% at Rs 320, while Sun Pharma up 1% at Rs 622 on the BSE, against 0.39% fall in Sensex at 09:27 am
 "Sun Pharma Advanced Research, Sun Pharma gain in weak market")
Sun Pharma extends fall; stock down 15% in 14 trading days
The stock dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016
 "Sun Pharma extends fall; stock down 15% in 14 trading days")
Delay in Halol plant resolution to hurt Sun Pharma's FY18 profit
Credit Suisse cuts FY18 profit estimate by 5%
 "Delay in Halol plant resolution to hurt Sun Pharma's FY18 profit")
US FDA finds quality control problems at Sun Pharma's Halol plant
The violations listed by the FDA after its latest inspection at Halol include problems with Sun's quality control system
US FDA listed 9 observations in notice of concerns over Halol plant: Sun Pharma
US FDA inspected the facility from November 17-December 1, 2016
Sun Pharma gains after falling 6% on Wednesday
The company said none of the nine observations were characterized by the USFDA as repeat observations
 "Sun Pharma gains after falling 6% on Wednesday")
US FDA raises fresh concerns on Sun Pharma's Halol plant
The Halol plant is a key manufacturing unit for Sun Pharma, which earns about half its revenue from the US market
Sun Pharma says US FDA finds more concerns at Halol plant
It is unclear what violations the FDA found; Sun did not disclose them
 "Sun Pharma says US FDA finds more concerns at Halol plant")
Sun Pharma dips 5% on confirmation of USFDA inspection of Halol facility
The stock was down 5% after the company confirms that Halol facility has undergone an inspection by USFDA
Sun Pharma tanks 4% on reports USFDA issued notice on Halol plant
The stock has shed 7% in the last 4 days, including today
 "Sun Pharma tanks 4% on reports USFDA issued notice on Halol plant")
Regulatory issues keep Sun Pharma stock under cloud
Stock is 40% below its all-time high touched last year
 "Regulatory issues keep Sun Pharma stock under cloud")
Sun Pharma's sharpens emerging market focus with $60 mn acquisition in Russia
Sun Pharma will pay $24 mn for 85% equity and will assume $36 mn debt as part of the transaction
 "Sun Pharma's sharpens emerging market focus with $60 mn acquisition in Russia")
Sun Pharma acquires Russian company for $60 million
Sun Pharma gained ownership of 85% of Biosintez's equity stake for $26 mn; it also owned a company debt of $36 mn
Sun Pharma ties up with Madhya Pradesh government to combat malaria
The funds for the same will come from the Corporate Social Responsibility funds earmarked by the company
Sun Pharma gains on strong Q2 results
The stock rallied 6% to Rs 708 on BSE in early morning trade.
Sun Pharma profit doubles on sales growth, licensing income
Net profit rises to Rs 2,235 crore in Q2 FY 17 as against Rs 1,028 crore in same period last year
 "Sun Pharma profit doubles on sales growth, licensing income")
Sun Pharma Q2 net up over two-fold at Rs 2,235 cr
Sales in its largest market, the United States, rose 9%, while those in India rose 11% in emerging markets
 "Sun Pharma Q2 net up over two-fold at Rs 2,235 cr")
Cartelisation probe against Dr Reddy's, Sun Pharma in US
Pharma stocks tumble 4% on BSE; Sun Pharma down 7.4%, Dr Reddy's loses 5.6%
 "Cartelisation probe against Dr Reddy's, Sun Pharma in US")
